The bone marrow hMSCs reduced interferon gamma-producing inflammatory cells, but increased IL-4 producing anti-inflammatory cells, thereby increasing oligodendrocyte lineage in EAE mouse model of MS [353]. Here, IFNG is linked to myeloid sarcoma.